Mitochondrial DNA haplogroups and neurocognitive impairment during HIV infection

Clinical Infectious Diseases

Volumn 61, Issue 9, 2015, Pages 1476-1484

  Hulgan, Todd ^a   Samuels, David C ^a   Bush, William ^a,i   Ellis, Ronald J ^b   Letendre, Scott L ^b   Heaton, Robert K ^b   Franklin, Donald R ^b   Straub, Peter ^a   Murdock, Deborah G ^a,j   Clifford, David B ^c   Collier, Ann C ^d   Gelman, Benjamin B ^e   Marra, Christina M ^d   Mcarthur, Justin C ^f   Mccutchan, J Allen ^b   Morgello, Susan ^g   Simpson, David M ^g   Grant, Igor ^b   Kallianpur, Asha R ^h  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY   (United States)

^j CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

AIDS; cognitive disorders; DNA, mitochondrial; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CELL NUCLEUS DNA; MITOCHONDRIAL DNA; VIRUS RNA;

ADULT; AFRICAN; AGED; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DNA SEQUENCE; ETHNIC DIFFERENCE; EUROPEAN; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLOBAL DEFICIT SCORE; HISPANIC; HIV ASSOCIATED DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL HAPLOGROUP; NEUROLOGIC DISEASE ASSESSMENT; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; READING; SCORING SYSTEM; WIDE RANGE ACHIEVEMENT TEST; ADOLESCENT; COMPLICATION; CROSS-SECTIONAL STUDY; GENETIC ASSOCIATION STUDY; GENETICS; HAPLOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AIDS DEMENTIA COMPLEX; CROSS-SECTIONAL STUDIES; DNA, MITOCHONDRIAL; FEMALE; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84946811558     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ527     Document Type: Article

References (40)

1. Clifford DB, Ances BM. HIV-Associated neurocognitive disorder. Lancet Infect Dis 2013; 13:976-86.
2. Heaton RK, Franklin DR Jr, Deutsch R, et al. Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study. Clin Infect Dis 2015; 60:473-80.
3. Grant I, Franklin DR Jr, Deutsch R, et al. Asymptomatic HIV-Associated neurocognitive impairment increases risk for symptomatic decline. Neurology 2014; 82:2055-62.
4. Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-Associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-96.
5. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-Associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011; 17:3-16.
6. van Rij RP, Portegies P, Hallaby T, et al. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex. J Infect Dis 1999; 180:854-7.
7. Corder EH, Robertson K, Lannfelt L, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998; 4:1182-4.
8. Morgan EE, Woods SP, Letendre SL, et al. Apolipoprotein E4 genotype does not increase risk of HIV-Associated neurocognitive disorders. J Neurovirol 2013; 19:150-6.
9. Panos SE, Hinkin CH, Singer EJ, et al. Apolipoprotein-E genotype and human immunodeficiency virus-Associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehav HIV Med 2013; 5:11-22.
10. Kallianpur AR, Levine AJ. Host genetic factors predisposing to HIVassociated neurocognitive disorder. Curr HIV/AIDS Rep 2014; 11: 336-52.
11. Levine AJ, Service S, Miller EN, et al. Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults. Am J Med Genet B Neuropsychiatr Genet 2012; 159B:669-83.
12. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39:359-407.
13. Mancuso M, Filosto M, Orsucci D, Siciliano G. Mitochondrial DNA sequence variation and neurodegeneration. Hum Genomics 2008; 3:71-8.
14. Hart AB, Samuels DC, Hulgan T. The other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapy. AIDS Rev 2013; 15:213-20.
15. Cristina Kenney M, Chwa M, Atilano SR, et al. Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions. Hum Mol Genet 2014; 23:3537-51.
16. Trudler D, Nash Y, Frenkel D. New insights on Parkinson?s disease genes: the link between mitochondria impairment and neuroinflammation. J Neural Transm 2015; doi:10.1007/s00702-015-1399-z.
17. Little J, Higgins JP, Ioannidis JP, et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 2009; 6:e22.
18. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults Scoring Program. Odessa, FL: Psychological Assessment Resources, Inc., 2004.
19. Norman MA, Moore DJ, Taylor M, et al. Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol 2011; 33:793-804.
20. Blackstone K, Moore DJ, Franklin DR, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol 2012; 26:894-908.
21. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 2004; 26:759-78.
22. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-Associated neurocognitive disorders. Neurology 2007; 69: 1789-99.
23. Xie HM, Perin JC, Schurr TG, et al. Mitochondrial genome sequence analysis: a custom bioinformatics pipeline substantially improves Affymetrix MitoChip v2.0 call rate and accuracy. BMC Bioinformatics 2011; 12:402.
24. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999; 23:147.
25. Kloss-Brandstatter A, Pacher D, Schonherr S, et al. HaploGrep: a fast and reliable algorithm for automatic classification of mitochondrial DNA haplogroups. Hum Mutat 2011; 32:25-32.
26. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 2006; 38:904-9.
27. Hall JB, Dumitrescu L, Dilks HH, Crawford DC, Bush WS. Accuracy of administratively-Assigned ancestry for diverse populations in an electronic medical record-linked biobank. PloS One 2014; 9:e99161.
28. Mitchell SL, Goodloe R, Brown-Gentry K, Pendergrass SA, Murdock DG, Crawford DC. Characterization of mitochondrial haplogroups in a large population-based sample from the United States. Hum Genet 2014; 133:861-8.
29. Li H, Cai X, Winograd-Cort ER, et al. Mitochondrial DNA diversity and population differentiation in southern East Asia. Am J Phys Anthropol 2007; 134:481-8.
30. Allard MW, Polanskey D, Wilson MR, Monson KL, Budowle B. Evaluation of variation in control region sequences for Hispanic individuals in the SWGDAM mtDNA data set. J Forensic Sci 2006; 51:566-73.
31. van OvenM, KayserM. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 2009; 30:E386-94.
32. Tiao MM, Liou CW, Huang LT, et al. Associations of mitochondrial haplogroups b4 and e with biliary atresia and differential susceptibility to hydrophobic bile Acid. PLoS Genet 2013; 9:e1003696.
33. Guardado-Estrada M, Medina-Martinez I, Juarez-Dorres E, et al. The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved. J Hum Genet 2012; 57:269-76.
34. Hulgan T, Levinson R, Gerschenson M, et al. Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapy. AIDS 2014; 28:1625-33.
35. Zhang Y, Wang M, Li H, et al. Accumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIVassociated neurocognitive disorders. Brain Res 2012; 1458:1-11.
36. Bi R, ZhangW, Yu D, et al. Mitochondrial DNA haplogroup B5 confers genetic susceptibility to Alzheimer?s disease in Han Chinese. Neurobiol Aging 2015; 36:1604 e7-16.
37. Lopez-Armada MJ, Riveiro-Naveira RR, Vaamonde-Garcia C, Valcarcel-Ares MN. Mitochondrial dysfunction and the inflammatory response. Mitochondrion 2013; 13:106-18.
38. Nightingale S, Winston A, Letendre S, et al. Controversies in HIVassociated neurocognitive disorders. Lancet Neurol 2014; 13:1139-51.
39. Casaletto KB, Umlauf A, Beaumont JL, et al. Demographically corrected normative standards for the English version of the NIH Toolbox Cognition Battery. J Int Neuropsychol Soc 2015; 21:378-91.
40. Levran O, Awolesi O, Shen PH, Adelson M, Kreek MJ. Estimating ancestral proportions in a multi-ethnic US sample: implications for studies of admixed populations. Hum Genomics 2012; 6:2.